blood product

blood product

A component—e.g., plasma, platelets, packed red cells—of whole blood, which is routinely used in surgery and other medical procedures.

blood product

A general term for a biopharmaceutical purified from human blood–eg factor VIII, fresh frozen plasma–FFP
References in periodicals archive ?
Contract notice: fluid and blood product infusion heaters
Since the product launch in early 2017, MaxPlus systems have helped over 100 hospitals and eight blood centers in the United States and Canada reduce blood product wastage due to temperature excursion.
(6) In later years, a form of GVHD--(transfusion-associated GVHD, or TA-GVHD)--was recognized in immunocompromised patients following nonirradiated, nonrelated-donor blood product transfusions.
The protocol allows for an acceptable ratio of transfused products and facilitates rapid blood product delivery with minimal waste.
Such blood product savings clearly make blood banks more efficient (Haldiman, Zia, & Singh, 2014; O'Keeffe et al., 2008).
A negative bodily reaction to a blood product is a possible complication of any transfusion.
The company stated the Via Blood Transporter maintains red blood cells at 1-6[degree sign]C for eight hours during transport and 1-10[degree sign]C for the temporary storage of blood product for a minimum of 12 hours.
The provisions in the Act restricting payment for the importation, acquisition or supply of tissue, blood, blood products or gametes are specific: it is an offence for a donor of tissue, a gamete, blood or a blood product to receive financial or other reward for such donation except for reimbursing their reasonable costs incurred (e.g.
In the Royal Prince Alfred (RPA) haematology ward, almost a third of patients receiving treatment for serious illnesses, including cancer, need some type of blood product to aid their recovery.
The American Red Cross recommends that recipients of YF vaccine defer blood product donation for 2 weeks because of the theoretical risk for transmission from a viremic donor (3).
The investigators said that prospective studies are needed to investigate the relationship between the blood product transfusion and immunosuppression in pediatric trauma patients.
Mitsubishi Tanabe is the successor to defunct blood product maker Green Cross Corp., which made the tainted fibrinogen blood products that caused a large number of people to contract hepatitis C.